Now showing items 1-1 of 1
Cholinekinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target
(2016-05-01) - Journal article
Background: The androgen receptor (AR) is a major drug target in prostate cancer (PCa). We profiled the AR-regulated kinome to identify clinically relevant and druggable effectors of AR signaling. Methods: Using genome-wide ...